Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reda Rawi

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Scientific Reports|February 22, 2020
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine ImmunogenLi Ou, Wing-Pui Kong, Gwo-Yu Chuang, et al.
Annals of the New York Academy of Sciences|November 16, 2022
Antibodies as drugs-a Keystone Symposia reportJennifer Cable, Erica Ollmann Saphire, Adrian C Hayday, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 5, 2024
Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1Jianliang Xu, Tongqing Zhou, Krisha McKee, et al.
Immunity|March 18, 2018
A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV EnvelopeTongqing Zhou, Anqi Zheng, Ulrich Baxa, et al.
Cell Host & Microbe|March 5, 2020
VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing LineageChen-Hsiang Shen, Brandon J DeKosky, Yicheng Guo, et al.
Journal of Virology|April 26, 2023
Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV NeutralizationMallika Sastry, Anita Changela, Jason Gorman, et al.
Cell Reports|July 12, 2023
HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptideShuishu Wang, Flavio Matassoli, Baoshan Zhang, et al.
Iscience|August 9, 2023
Soluble prefusion-closed HIV-envelope trimers with glycan-covered basesAdam S Olia, Cheng Cheng, Tongqing Zhou, et al.
Cell Reports|April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody ElicitationTongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus MacaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Scientific Reports|February 22, 2020
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine ImmunogenLi Ou, Wing-Pui Kong, Gwo-Yu Chuang, et al.
Annals of the New York Academy of Sciences|November 16, 2022
Antibodies as drugs-a Keystone Symposia reportJennifer Cable, Erica Ollmann Saphire, Adrian C Hayday, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 5, 2024
Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1Jianliang Xu, Tongqing Zhou, Krisha McKee, et al.
Immunity|March 18, 2018
A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV EnvelopeTongqing Zhou, Anqi Zheng, Ulrich Baxa, et al.
Cell Host & Microbe|March 5, 2020
VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing LineageChen-Hsiang Shen, Brandon J DeKosky, Yicheng Guo, et al.
Journal of Virology|April 26, 2023
Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV NeutralizationMallika Sastry, Anita Changela, Jason Gorman, et al.
Cell Reports|July 12, 2023
HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptideShuishu Wang, Flavio Matassoli, Baoshan Zhang, et al.
Iscience|August 9, 2023
Soluble prefusion-closed HIV-envelope trimers with glycan-covered basesAdam S Olia, Cheng Cheng, Tongqing Zhou, et al.
Cell Reports|April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody ElicitationTongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus MacaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Pageof 9